<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00472472</url>
  </required_header>
  <id_info>
    <org_study_id>PACCOCATH - FEM I</org_study_id>
    <nct_id>NCT00472472</nct_id>
  </id_info>
  <brief_title>Paclitaxel Coated Balloon Catheter for Prevention of Restenosis in Femoropopliteal Arteries</brief_title>
  <acronym>PACCOCATH_F</acronym>
  <official_title>Paclitaxel Coated Balloon Catheter for Inhibition of Restenosis in Femoropopliteal Arteries (PACCOCATH - FEM I)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Saarland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Saarland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PACCOCATH FEM study is a randomized, double-blinded German multicenter trial on the
      efficacy and tolerance of a paclitaxel coated balloon catheter in prevention of restenosis
      after femoropopliteal angioplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Treatment of patients with peripheral arterial disease (PAD) in the
      femoropopliteal arteries by percutaneous intervention is still limited by high rates of
      restenosis. The aim of the present study is to evaluate the efficacy and safety of a novel
      method of short time local drug delivery based on a paclitaxel-coated balloon in
      femoropopliteal arteries.

      Methods and results: The double-blind and randomized study enrolled n=79 patients with
      occlusion or stenosis of femoropopliteal arteries. Inclusion criteria were clinical
      Rutherford stage 1-5, occlusion or hemodynamic relevant stenosis (≥ 70 % diameter) of
      femoropopliteal arteries and successful guiding wire recanalization. The primary endpoint was
      the late lumen loss after 6 months follow-up as seen in angiography. Secondary endpoints
      included the rate of restenosis (a binary variable), change of ankle brachial index (ABI),
      rutherford class and major adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2004</start_date>
  <completion_date type="Actual">July 2007</completion_date>
  <primary_completion_date type="Actual">July 2007</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>angiographic late lumen loss</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>binary restenosis rate; major adverse events</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">87</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>PTA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PTA with Paccocath</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>paclitaxel coated balloon catheter (device with drug)</intervention_name>
    <description>PTA vs Paccocath</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Rutherford stage 1, 2, 3, 4 oder 5

          -  Occlusion or Stenosis of Superficial femoral and/or popliteal artery

          -  Successful guide wire passage of the lesion

          -  Patient suitable of vascular surgery in case of complication

          -  Written consent

          -  Patient is willing to take part in follow up examinations within the study

        Exclusion Criteria:

          -  Acute ischemia

          -  Distal run off less than one vessel

          -  Pregnancy

          -  Hyperthyroidism

          -  Thrombocytes &lt;100.000/mm3 or &gt;700.000/mm3, Leucocytes &lt;3.000/mm3

          -  Life expectancy less than two years

          -  Patients not willing to enter the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Ricke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik für Strahlenheilkunde, Charité Campus Virchow, Augustenburger Platz 1, 13353 Berlin, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ulrich Speck, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Radiologie, Campus Mitte, Charite, 10117 Berlin, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinik für Strahlenheilkunde, Charité Campus Virchow Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut für Diagnostische Radiologie und Neuroradiologie, Universitätsklinikum Greifswald der Ernst-Moritz-Arndt-Universität</name>
      <address>
        <city>Greifswald</city>
        <zip>17487</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004 Aug 17;110(7):810-4. Epub 2004 Aug 9.</citation>
    <PMID>15302790</PMID>
  </reference>
  <reference>
    <citation>Speck U, Scheller B, Abramjuk C, Grossmann S, Mahnkopf D, Simon O. Inhibition of restenosis in stented porcine coronary arteries: uptake of Paclitaxel from angiographic contrast media. Invest Radiol. 2004 Mar;39(3):182-6.</citation>
    <PMID>15076010</PMID>
  </reference>
  <reference>
    <citation>Scheller B, Speck U, Schmitt A, Böhm M, Nickenig G. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J Am Coll Cardiol. 2003 Oct 15;42(8):1415-20.</citation>
    <PMID>14563585</PMID>
  </reference>
  <reference>
    <citation>Scheller B, Speck U, Romeike B, Schmitt A, Sovak M, Böhm M, Stoll HP. Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur Heart J. 2003 Aug;24(15):1462-7.</citation>
    <PMID>12909076</PMID>
  </reference>
  <reference>
    <citation>Scheller B, Speck U, Böhm M. Prevention of restenosis: is angioplasty the answer? Heart. 2007 May;93(5):539-41.</citation>
    <PMID>17435062</PMID>
  </reference>
  <reference>
    <citation>Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Böhm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006 Nov 16;355(20):2113-24. Epub 2006 Nov 13.</citation>
    <PMID>17101615</PMID>
  </reference>
  <reference>
    <citation>Speck U, Scheller B, Abramjuk C, Breitwieser C, Dobberstein J, Boehm M, Hamm B. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology. 2006 Aug;240(2):411-8.</citation>
    <PMID>16864669</PMID>
  </reference>
  <verification_date>May 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 10, 2007</study_first_submitted>
  <study_first_submitted_qc>May 10, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2007</study_first_posted>
  <last_update_submitted>June 29, 2010</last_update_submitted>
  <last_update_submitted_qc>June 29, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 30, 2010</last_update_posted>
  <responsible_party>
    <name_title>Charite Hospital, Berlin</name_title>
    <organization>Charite Hospital, Berlin</organization>
  </responsible_party>
  <keyword>restenosis</keyword>
  <keyword>peripheral arterial disease</keyword>
  <keyword>paccocath</keyword>
  <keyword>drug-coated balloon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

